Genetic cancer evaluation
iCellate’s genetic cancer evaluation, using circulating tumor cells (CTC) or circulating tumor DNA (ctDNA), provides detailed genetic tumor information which may reveal new targeted treatment options.
Inherited cancer risk
Cancer in the family can cause great and sometimes unnecessary concern. From blood samples, iCellate can analyze the DNA, assess the inherited risk for cancer and suggest actions to take.